Parkinson's patients watched closely in new study
NCT ID NCT05779475
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 19 times
Summary
This study follows 96 people with moderate Parkinson's disease to see how their symptoms change over 3 to 24 months. Participants continue their usual medications, and doctors may adjust them for better symptom control. The study does not test a new treatment but aims to better understand the disease's progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Neuroscience
Cambridge, CB2 0PY, United Kingdom
-
Joe C.Wen & Fam CTR for Adv Care
Irvine, California, 92612, United States
-
Keio University Hospital
Shinjuku-ku, Tokyo, 160-8582, Japan
-
NY Presbyt Hosp-W Cornell Med
New York, New York, 10021, United States
-
NYU Langone Health
New York, New York, 10016, United States
-
Neurologimottagningen Lund
Lund, 222 42, Sweden
-
Region Skane Skanes Universitetssjukhus
Lund, 222 42, Sweden
-
University of Cambridge - Clinical Neuroscience
Cambridge, CB2 0PY, United Kingdom
Conditions
Explore the condition pages connected to this study.